Lexicon Pharmaceuticals
Home
Contact Us
Site Map
About Us
About Us Home
Management Team
Board of Directors
Development Team
Locations
Contact Us
History
Pipeline
Drug Pipeline Home
Our Goal
Therapeutic Areas
Drug Development Team
Clinical Trials
Publications
Discovery
Discovery Home
Discovery Process
Technology
Genome5000
Medicinal Chemistry
Patents
Academic Access
Technology Licensing
Scientific Publications
Alliances
Alliances Home
Current Alliances
Technology Licensing
Careers
Careers Home
Opportunities
Our Culture
Benefits
Community Involvement
The Woodlands
Princeton
Awards and Recognition
News
News Home
Media Inquiries
Investors
Investors Home
Media
Events
Stock Quote
SEC Filings
Annual Reports
Corporate Governance
Request Information
News Home
Media Inquiries
Subscribe
Press Releases
Filter
Display #
5
10
15
20
25
30
50
100
All
01/03/2008
Lexicon Pharmaceuticals to Present at the 26th Annual JPMorgan Healthcare Conference
12/21/2007
Lexicon Files Investigational New Drug Application for LX1032 as a Potential Treatment for Carcinoid Syndrome
12/10/2007
Lexicon Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference
12/05/2007
Lexicon Initiates Phase 2A Trial of LX6171 Drug Candidate for Cognitive Disorders
11/26/2007
Lexicon Pharmaceuticals to Present at the Piper Jaffray 19th Annual Health Care Conference
11/12/2007
Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
10/30/2007
Lexicon Pharmaceuticals Reports 2007 Third Quarter Financial Results
10/22/2007
Lexicon to Report Third Quarter 2007 Financial Results on October 30, 2007
10/15/2007
Lexicon Reports Initial Clinical Trial Results for LX1031, An Investigational New Drug For Irritable Bowel Syndrome
10/04/2007
Lexicon Pharmaceuticals to Present at BIO InvestorForum
«
Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End
»
Page 8 of 37
